Jinyan Du

10.7k total citations · 3 hit papers
37 papers, 6.3k citations indexed

About

Jinyan Du is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jinyan Du has authored 37 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cell Biology and 10 papers in Oncology. Recurrent topics in Jinyan Du's work include melanin and skin pigmentation (13 papers), Melanoma and MAPK Pathways (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Jinyan Du is often cited by papers focused on melanin and skin pigmentation (13 papers), Melanoma and MAPK Pathways (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Jinyan Du collaborates with scholars based in United States, Germany and China. Jinyan Du's co-authors include David E. Fisher, Todd R. Golub, Hans R. Widlund, Sridhar Ramaswamy, Martin A. Horstmann, Emi K. Nishimura, Rameen Beroukhim, Scott R. Granter, Joshua Gould and Dennie T. Frederick and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Jinyan Du

36 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

2012 1.4k citations Jinyan Du, Todd R. Golub et al. Nature profile →
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

2005 1.1k citations Levi A. Garraway, Hans R. Widlund et al. Nature profile →
Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

2002 578 citations Gaël McGill, Martin A. Horstmann et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinyan Du United States	26	4.2k	2.1k	1.6k	1.0k	1.0k	37	6.3k
Hans R. Widlund United States	39	6.4k 1.5×	2.3k 1.1×	2.5k 1.6×	1.6k 1.5×	1.4k 1.3×	59	8.9k
Keiran S.M. Smalley United States	53	5.9k 1.4×	4.0k 1.9×	1.3k 0.8×	837 0.8×	1.2k 1.1×	173	8.5k
Claudia Wellbrock United Kingdom	32	4.0k 1.0×	2.2k 1.0×	1.2k 0.7×	627 0.6×	1.1k 1.1×	57	5.6k
Brian Gabrielli Australia	47	4.6k 1.1×	2.1k 1.0×	1.6k 1.0×	887 0.9×	412 0.4×	129	6.0k
David T. Weaver United States	49	6.5k 1.5×	2.6k 1.3×	747 0.5×	1.3k 1.3×	1.4k 1.3×	150	9.0k
Domenico Delia Italy	43	4.2k 1.0×	2.5k 1.2×	453 0.3×	1.2k 1.2×	950 0.9×	125	6.9k
Paolo Nucíforo Spain	42	4.1k 1.0×	3.4k 1.6×	699 0.4×	1.8k 1.7×	901 0.9×	175	7.3k
Thomas Kuilman Netherlands	16	3.8k 0.9×	1.9k 0.9×	519 0.3×	1.2k 1.1×	1.4k 1.4×	25	6.7k
Nikolas K. Haass Australia	36	2.8k 0.7×	1.7k 0.8×	822 0.5×	579 0.6×	572 0.6×	99	4.3k
Norbert Kraut Austria	33	5.0k 1.2×	2.7k 1.3×	1.7k 1.1×	1.4k 1.4×	635 0.6×	72	7.2k

Countries citing papers authored by Jinyan Du

Since Specialization

Citations

This map shows the geographic impact of Jinyan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyan Du more than expected).

Fields of papers citing papers by Jinyan Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyan Du. The network helps show where Jinyan Du may publish in the future.

Co-authorship network of co-authors of Jinyan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyan Du. A scholar is included among the top collaborators of Jinyan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyan Du. Jinyan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Jinyan, Xiaoling Huang, Yaxin Li, et al.. (2024). Buyang huanwu decoction improves synaptic plasticity of ischemic stroke by regulating the cAMP/PKA/CREB pathway. Journal of Ethnopharmacology. 335. 118636–118636. 8 indexed citations

Du, Jinyan, et al.. (2024). Application and Optimization of Multi-Factor Authentication and Biometric Technology in Power Grid Energy Network Access Control. Renewable Energy and Power Quality Journal. 118–131. 1 indexed citations

Wu, Ying, Jinyan Du, Zi Xie, et al.. (2023). The mechanisms of Huangqi Guizhi Wuwu decoction in treating ischaemic stroke based on network pharmacology and experiment verification. Pharmaceutical Biology. 61(1). 1014–1029. 8 indexed citations

Iglesias, Pablo, Julia Strauß, Ann‐Christin Puller, et al.. (2019). Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair. Oncogene. 38(19). 3616–3635. 14 indexed citations

Cho, Jeonghee, Sujin Kim, Jinyan Du, & Matthew Meyerson. (2018). Autophosphorylation of the carboxyl‐terminal domain is not required for oncogenic transformation by lung‐cancer derived EGFR mutants. International Journal of Cancer. 143(3). 679–685. 9 indexed citations

Kumar, Manu P., Jinyan Du, Georgia Lagoudas, et al.. (2018). Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics. Cell Reports. 25(6). 1458–1468.e4. 278 indexed citations

Puissant, Alexandre, Nina Fenouille, Gabriela Alexe, et al.. (2014). SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia. Cancer Cell. 25(2). 226–242. 109 indexed citations

Dadras, Soheil S., Richard J. Lin, Akinori Kawakami, et al.. (2014). A Novel Role for Microphthalmia-Associated Transcription Factor–Regulated Pigment Epithelium-Derived Factor during Melanoma Progression. American Journal Of Pathology. 185(1). 252–265. 14 indexed citations

Crompton, Brian D., Aaron R. Thorner, Amanda L. Christie, et al.. (2013). High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma. Cancer Research. 73(9). 2873–2883. 42 indexed citations

10.

Guo, Junming, Jinyan Du, & David J. Kwiatkowski. (2013). Molecular Dissection of AKT Activation in Lung Cancer Cell Lines. Molecular Cancer Research. 11(3). 282–293. 31 indexed citations

11.

Cho, Nancy L., Jinyan Du, Edward E. Whang, et al.. (2012). Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers. Biochemical and Biophysical Research Communications. 421(3). 508–513. 14 indexed citations

12.

Cheung, Hiu Wing, Jinyan Du, Jesse S. Boehm, et al.. (2011). Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers. Cancer Discovery. 1(7). 608–625. 110 indexed citations

13.

Shrestha, Yashaswi, Eric J. Schafer, Jesse S. Boehm, et al.. (2011). PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 31(29). 3397–3408. 124 indexed citations

14.

Lin, Chi‐Iou, Edward E. Whang, David B. Donner, et al.. (2010). Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer. Molecular Cancer Research. 8(9). 1217–1226. 95 indexed citations

15.

Nishimura, Emi K., Misa Suzuki, Vivien Igras, et al.. (2010). Key Roles for Transforming Growth Factor β in Melanocyte Stem Cell Maintenance. Cell stem cell. 6(2). 130–140. 175 indexed citations

16.

Du, Jinyan, Karl R. Clauser, D.R. Mani, et al.. (2008). Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology. 27(1). 77–83. 192 indexed citations

17.

Davis, Ian J., Jessica Kim, Fatih Ozsolak, et al.. (2006). Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers. Cancer Cell. 9(6). 473–484. 152 indexed citations

18.

Garraway, Levi A., Hans R. Widlund, Mark A. Rubin, et al.. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 436(7047). 117–122. 1107 indexed citations breakdown →

19.

Du, Jinyan, Arlo J. Miller, Hans R. Widlund, et al.. (2003). MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma. American Journal Of Pathology. 163(1). 333–343. 224 indexed citations

20.

McGill, Gaël, Martin A. Horstmann, Hans R. Widlund, et al.. (2002). Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability. Cell. 109(6). 707–718. 578 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact